Treating inflammatory arthritis in individuals with concomitant cancer

IF 29.4 1区医学 Q1 RHEUMATOLOGY

Nature Reviews Rheumatology Pub Date : 2025-03-13 DOI:10.1038/s41584-025-01235-8

Maria E. Suarez-Almazor

引用次数: 0

Abstract

Treating people with inflammatory arthritis and cancer is challenging given concerns around suppressing anti-tumour immunity. Targeted therapies, such as TNF inhibitors, can be safely used in patients with cancer who are in remission, but whether these treatments are safe for individuals with newly diagnosed or active cancer remains unclear.

查看原文本刊更多论文

治疗伴有癌症的炎症性关节炎

治疗炎症性关节炎和癌症患者具有挑战性，因为人们担心会抑制抗肿瘤免疫。靶向治疗，如肿瘤坏死因子抑制剂，可以安全地用于处于缓解期的癌症患者，但这些治疗对新诊断或活动性癌症患者是否安全仍不清楚。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Rheumatology 医学-风湿病学

CiteScore

29.90

自引率

0.90%

发文量

137

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Rheumatology is part of the Nature Reviews portfolio of journals. The journal scope covers the entire spectrum of rheumatology research. We ensure that our articles are accessible to the widest possible audience.